Author:
Uwaydah M,Vartivarian S,Shatila S,Raad I,Harakeh H,Nassar N T
Abstract
Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. Datta N. H. Richards and C. Datta. 1981. Salmonella typhi in vivo acquires resistance to both chloramphenicol and cotrimoxazole. Lancet i:1181-1183.
2. The antibiotic treatment of typhoid fever;Geddes A. M.;J. Antimicrob. Chemother.,1977
3. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic;Goto S.;Rev. Infect. Dis.,1982
4. New trends in the chemotherapy of typhoid fever;Herzog C.;Acta Trop.,1980
5. Hornick R. B. 1983. Typhoid fever p. 662-668. In P. D. Hoeprich (ed.) Infectious diseases 3rd ed. J. P. Lippincott Co. Philadelphia.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献